Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19

Eiman Elhouderi; Eman Elsawalhy; Mohamed Kabbani

doi:10.7759/cureus.25264

Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19

Cureus. 2022 May 23;14(5):e25264. doi: 10.7759/cureus.25264. eCollection 2022 May.

Authors

Eiman Elhouderi¹, Eman Elsawalhy¹, Mohamed Kabbani¹

Affiliation

¹ Internal Medicine, Beaumont Health, Dearborn, USA.

Abstract

Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment.

Keywords: covid-19 infection; covid-19 vaccine; m-rna vaccine; myocarditis; pericarditis.

Publication types

Case Reports